PT  - JOURNAL ARTICLE
AU  - Pang, Juanita
AU  - Boshier, Florencia A.T.
AU  - Alders, Nele
AU  - Dixon, Garth
AU  - Breuer, Judith
TI  - No evidence of viral polymorphisms associated with Paediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2 (PIMS-TS)
AID  - 10.1101/2020.07.07.20148213
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.07.07.20148213
4099  - http://medrxiv.org/content/early/2020/07/08/2020.07.07.20148213.short
4100  - http://medrxiv.org/content/early/2020/07/08/2020.07.07.20148213.full
AB  - Generally, children and teenagers do not become seriously ill with COVID-19. However, in countries with high rates of coronavirus disease, children with the syndrome COVID-19 associated inflammation syndrome referred to as PIMS-TS have been reported. Similarities noted between SARS-CoV-2 Spike protein sequences and those of other super antigens has prompted the suggestion that this might be the mechanism by SARS-CoV-ST triggers PIMS-TS. It has also been suggested that the D614G variant found more commonly in the US and across European countries may explain why PIMS-TS appears to be common in these countries. Here we analysed viral sequences from 13 paediatric COVID-19 patients of whom five were diagnosed with PIMS-TS. This is the first characterisation of viruses from PIMS-TS patients. In contrast to what has been hypothesised, we found no evidence of unique sequences associated with the viruses from PIMS-TS patients.Competing Interest StatementThe authors have declared no competing interest.Funding Statementthis work was supported by the John Black Charitable foundationAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The National Research Ethics Service (NRES) Committee London Fulham (REC reference: 17/LO/1530)All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.Yesall the sequences have been submitted to COG-UK and are freely available in the MRC CLIMB database